Freenome, Inc. FRNM
At closeNov 3, 2026, 4:00 PM EST
After hours · Nov 3, 4:00 PM ET
- YTD
- -11.97%
- 1 year
- +6.90%
- Market cap
- 1.23B
- Revenue (ttm)
- 35.41M
- EPS (ttm)
- -2.04
- Shares out
- 107.45M
- Forward P/E
- -4.78
- YTD return
- -11.97%
- 1-year return
- +6.90%
- Volume
- 534.58K
- Avg volume
- 831.69K
- Open
- 12.00
- Previous close
- 11.61
- Day's range
- 11.43 – 12.17
- 52-week range
- 9.95 – 17.50
- Beta
- 0.60
- Analysts
- Strong Buy
- Price target
- 18.00 (+56.9%)
- Earnings date
- Nov 10, 2026
3M +0.56 (+5.13%)
Key statistics
- Enterprise value
- 2.82B
- PEG ratio
- 0.00
- Price / sales
- 34.80
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 106.50%
- Free cash flow
- 0
- Total cash
- 102.02M
- Total debt
- 311.45M
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 14.69
- 200-day average
- 12.50
Analyst view
Consensus: strong buy
- Target (low)
- 17.00
- Target (mean)
- 18.00
- Target (high)
- 21.00
- Strong buy0
- Buy5
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 10, 2026
Expected Nov 10, 2026. Consensus EPS estimate -0.195.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 10, 2026 | Sep 30, 2026 | 0.1375 | — | — | — |
| Jul 15, 2026 | Jun 30, 2026 | -1.78 | -1.91 | -0.13 | -7.61% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 2026 | Guggenheim | init | — | Buy |
| Aug 18, 2026 | TD Cowen | init | — | Buy |
| Aug 17, 2026 | Jefferies | init | — | Buy |
| Aug 17, 2026 | BTIG | init | — | Buy |
About Freenome, Inc.
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- freenome.com
News
Your note
Sign in to keep a note on FRNM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALTMAN MICHAEL SETH | Former | Conversion of Exercise of derivative security | Jul 19, 2026 | 0 |
| EDELMAN JOSEPH E | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jul 19, 2026 | 0 |
| MCKENNA MARK C | Former | Conversion of Exercise of derivative security | Jul 19, 2026 | 30,000 |
| PERCEPTIVE CAPITAL SOLUTIONS HOLDINGS | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jul 19, 2026 | 0 |
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jul 19, 2026 | 0 |
| SONG KENNETH M.D. | Former | Conversion of Exercise of derivative security | Jul 19, 2026 | 30,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Citizens Financial Group Inc/RI | 0.64% | 684,946 | 7.86M | Sep 29, 2026 |
| Wealth Enhancement Advisory Services, LLC | 0.27% | 290,453 | 3.33M | Sep 29, 2026 |
| Svrn Asset Management, LLC | 0.02% | 16,600 | 190.40K | Sep 29, 2026 |
| FNY Investment Advisers, LLC | 0.00% | 3,500 | 40.15K | Sep 29, 2026 |
| SBI Securities Co., Ltd. | 0.00% | 1,155 | 13.25K | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK Venture Fund | 1.88% | 2,019,291 | 23.16M | Jul 30, 2026 |
| ARK ETF Trust-ARK Genomic Revolution ETF | 0.69% | 742,035 | 8.51M | Sep 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 0.37% | 397,340 | 4.56M | Aug 30, 2026 |
| T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Global Stock Fd. | 0.22% | 238,855 | 2.74M | Jul 30, 2026 |
| Federated Hermes World Investment Series, Inc.-Federated Hermes Intl S | 0.09% | 100,000 | 1.15M | Aug 30, 2026 |
| iShares Trust-iShares Core S&P Total U.S. Stock Market ETF | 0.08% | 82,521 | 946.51K | Sep 29, 2026 |